Posted by Patrick Bannon on Nov 28th, 2024
Maxim Group initiated coverage on shares of Citius Oncology (NASDAQ:CTOR – Free Report) in a report issued on Wednesday morning, Marketbeat.com reports. The firm issued a buy rating and a $3.00 price target on the stock.
Citius...
More of this article »